Sample Digests
See what a curated research digest looks like. Real papers from top journals, structured summaries, tailored to specific research interests.
Sample Digest · Sample Digest
Solid Tumor Immunotherapy
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
Cercek A, Lumish M, Sinopoli J, et al.
Key Findings
- All 12 patients (100%) with mismatch repair–deficient locally advanced rectal cancer achieved complete clinical response to dostarlimab monotherapy
- At median follow-up of 12 months, no patient had received chemoradiotherapy or undergone surgery
- No adverse events of grade 3 or higher were reported during the treatment period
Why This Matters
A landmark result suggesting that a subset of rectal cancer patients may avoid surgery, radiation, and chemotherapy entirely through immunotherapy alone — directly relevant to anyone tracking checkpoint inhibitor response in solid tumors.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
Forde PM, Spicer J, Lu S, et al.
Key Findings
- CheckMate 816: neoadjuvant nivolumab plus platinum-doublet chemotherapy significantly improved event-free survival vs chemotherapy alone in resectable NSCLC (HR 0.63; P=0.005)
- Pathological complete response rate: 24.0% in the nivolumab-chemo arm versus 2.2% with chemotherapy alone
- Safety profile consistent with known profiles of the individual components; no new signals observed
Why This Matters
Establishes neoadjuvant immunotherapy as a new standard-of-care option in resectable lung cancer, shifting the treatment paradigm from post-surgical to pre-surgical checkpoint blockade.
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Munshi NC, Anderson LD Jr, Shah N, et al.
Key Findings
- KarMMa trial: anti-BCMA CAR-T therapy (ide-cel) achieved 73% overall response rate in heavily pretreated relapsed/refractory multiple myeloma
- Complete response rate of 33% at the target dose level; median progression-free survival of 8.8 months
- Cytokine release syndrome occurred in 84% of patients (grade 1–2 in most cases); neurotoxicity in 18%
This is a sample of 3 papers. A typical Tailored digest includes 10 papers per project (up to 40 total across 4 projects).
Peer-reviewed journals and preprint servers tracked weekly
Papers processed by our selection algorithm each week
Average time to scan your weekly digest over morning coffee
Get your own personalized digest
Define your research interests. Our advanced selection algorithm delivers the papers that matter to you, every Monday morning.